Suppr超能文献

结膜囊鼻腔吻合术后症状评分问卷的应用:结果。

Application of a symptoms score questionnaire after conjunctivodacryocystorhinostomy: outcomes.

机构信息

IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

Department of Surgical Sciences and Integrated Diagnostics (DISC), University of Genoa, Genoa, Italy.

出版信息

Acta Otorhinolaryngol Ital. 2021 Jun;41(3):248-254. doi: 10.14639/0392-100X-N0881.

Abstract

OBJECTIVE

To evaluate medium/long term outcomes and patient satisfaction through relief of symptoms and improved quality of life (QoL) after Jones tube conjunctivodacryocystorhinostomy (JT-CDCR) using the Naso Lacrimal Duct Obstruction symptom-score (NLDO-SS).

METHODS

We conducted a retrospective, non-comparative, multicentric study including patients with complete obstruction of the superior and inferior proximal lacrimal drainage system. All patients underwent JT-CDCR, and the patency of the tube was evaluated with saline irrigation and endoscopic examination. We assessed patient satisfaction and quality of life administering the NLDO-SS.

RESULTS

We enrolled 16 patients, for a total of 21 eyes operated. The success rate for procedures was 81%. The success rate for single parameters was globally 95.9%; if considered separately, ocular symptoms and nasal symptoms were respectively 94.3% and 100%.

CONCLUSIONS

JT-CDCR was a reliable procedure, able to solve symptoms in a majority of patients and guaranteed a good quality of life over a long period of time.

摘要

目的

通过使用 Naso Lacrimal Duct Obstruction symptom-score (NLDO-SS) 评估 Jones 管结膜囊鼻腔吻合术 (JT-CDCR) 后症状缓解和生活质量 (QoL) 改善的中/长期结果和患者满意度。

方法

我们进行了一项回顾性、非对照、多中心研究,纳入了完全性上下泪道近端阻塞的患者。所有患者均接受 JT-CDCR 治疗,并通过盐水冲洗和内镜检查评估导管通畅性。我们通过 NLDO-SS 评估患者满意度和生活质量。

结果

我们共纳入 16 名患者,共 21 只眼接受手术。手术成功率为 81%。单一参数的成功率总体为 95.9%;如果分别考虑,眼部症状和鼻部症状的成功率分别为 94.3%和 100%。

结论

JT-CDCR 是一种可靠的手术方法,能够解决大多数患者的症状,并在很长一段时间内保证良好的生活质量。

相似文献

1
Application of a symptoms score questionnaire after conjunctivodacryocystorhinostomy: outcomes.
Acta Otorhinolaryngol Ital. 2021 Jun;41(3):248-254. doi: 10.14639/0392-100X-N0881.
2
Long-Term Quality of Life in Patients Following Minimally Invasive Conjunctivodacryocystorhinostomy With StopLoss Jones Tube.
Ophthalmic Plast Reconstr Surg. 2022;38(2):170-175. doi: 10.1097/IOP.0000000000002017.
4
6
Endoscopic dacryocystorhinostomy as an option for symptomatic epiphora in isolated monocanalicular obstruction.
Orbit. 2021 Oct;40(5):419-422. doi: 10.1080/01676830.2020.1799420. Epub 2020 Jul 26.
8
Long-term outcomes of StopLoss™ Jones tube (SLJT) and minimally invasive conjunctivodacryocystorhinostomy.
Graefes Arch Clin Exp Ophthalmol. 2022 Jan;260(1):327-333. doi: 10.1007/s00417-021-05347-1. Epub 2021 Aug 12.
9
Outcomes of Endoscopic Dacryocystorhinostomy in Secondary Acquired Nasolacrimal Duct Obstruction: A Case-Control Study.
Ophthalmic Plast Reconstr Surg. 2018 Jan/Feb;34(1):20-25. doi: 10.1097/IOP.0000000000000841.
10
Modified conjunctivodacryocystorhinostomy for upper lacrimal system obstruction.
Arch Facial Plast Surg. 2007 Mar-Apr;9(2):96-100. doi: 10.1001/archfaci.9.2.96.

本文引用的文献

1
Multidisciplinary approach to lacrimal system diseases.
Acta Otorhinolaryngol Ital. 2021 Apr;41(Suppl. 1):S102-S107. doi: 10.14639/0392-100X-suppl.1-41-2021-10.
2
4
Can Lester Jones tubes be tolerated for decades?
Eye (Lond). 2018 Jan;32(1):142-145. doi: 10.1038/eye.2017.168. Epub 2017 Aug 18.
6
Surgical Outcomes of Endonasal Conjunctivodacryocystorhinostomy According to Jones Tube Location.
J Craniofac Surg. 2017 Jul;28(5):e500-e503. doi: 10.1097/SCS.0000000000003801.
7
Assessment of patient-reported outcome and quality of life improvement following surgery for epiphora.
Eye (Lond). 2017 Dec;31(12):1664-1671. doi: 10.1038/eye.2017.120. Epub 2017 Jun 16.
9
Assessing the Outcomes of Powered Endoscopic Dacryocystorhinostomy in Adults Using the Lacrimal Symptom (Lac-Q) Questionnaire.
Ophthalmic Plast Reconstr Surg. 2017 Jan/Feb;33(1):65-68. doi: 10.1097/IOP.0000000000000660.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验